ScoreComparison
Why is ImmunoPrecise Antibodies Ltd. ?
1
Poor Management Efficiency with a low ROE of 0%
- The company has reported losses. Due to this company has reported negative ROE
2
Negative results in Oct 25
- OPERATING CASH FLOW(Y) Lowest at USD -6.64 MM
- NET SALES(Q) At USD 2.97 MM has Fallen at -33.75%
- ROCE(HY) Lowest at -121.76%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 184.52%, its profits have risen by 23.2%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is ImmunoPrecise Antibodies Ltd. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
ImmunoPrecise Antibodies Ltd.
183.55%
0.09
127.95%
S&P 500
16.12%
0.77
19.29%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
3.16%
EBIT Growth (5y)
-187.62%
EBIT to Interest (avg)
-11.83
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.45
Sales to Capital Employed (avg)
0.74
Tax Ratio
9.85%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
10.51%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.44
EV to EBIT
-5.32
EV to EBITDA
-7.53
EV to Capital Employed
38.60
EV to Sales
3.07
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-725.59%
ROE (Latest)
-55.81%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
NET PROFIT(HY)
Higher at USD -5.29 MM
RAW MATERIAL COST(Y)
Fallen by -103.82% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -72.75 %
-16What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -6.64 MM
NET SALES(Q)
At USD 2.97 MM has Fallen at -33.75%
ROCE(HY)
Lowest at -121.76%
DEBTORS TURNOVER RATIO(HY)
Lowest at 4.27 times
Here's what is working for ImmunoPrecise Antibodies Ltd.
Net Profit
Higher at USD -5.29 MM
than preceding 12 month period ended Oct 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Debt-Equity Ratio
Lowest at -72.75 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -103.82% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for ImmunoPrecise Antibodies Ltd.
Net Sales
At USD 2.97 MM has Fallen at -33.75%
Year on Year (YoY)MOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
Operating Cash Flow
Lowest at USD -6.64 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Debtors Turnover Ratio
Lowest at 4.27 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
